Clinical trial

Neoadjuvant Trastuzumab and Letrozole for Postmenopausal Women

NCT02214004

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2015-03-01

PhasePHASE2

Study timeline

Study start (unknown)2015-03-01Date precision: month

Registry last updated2018-02-15

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Interventions

TrastuzumabDRUG · verified · RxNorm: trastuzumab

LetrozoleDRUG · verified · RxNorm: letrozole

Sponsors & collaborators

Gangnam Severance Hospitallead sponsor

Seoul National University Hospitalcollaborator

Severance Hospitalcollaborator

Samsung Medical Centercollaborator

Asan Medical Centercollaborator

Mapped research locations

SeoulSouth Korea8 BusanSouth Korea1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02214004 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.